The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease (Q34345151)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease |
scientific article |
Statements
1 reference
The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease (English)
1 reference
Richie Khanna
1 reference
John J Flanagan
1 reference
Jessie Feng
1 reference
Rebecca Soska
1 reference
Michelle Frascella
1 reference
Lee J Pellegrino
1 reference
Yi Lun
1 reference
Darlene Guillen
1 reference
David J Lockhart
1 reference
Kenneth J Valenzano
1 reference
18 July 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference